血清miR-499与急性冠脉综合征患者冠状动脉病变严重程度的相关性分析
|
|
唐冬娟, 江来, 江叶
|
Correlation analysis of serum miR-499 and severity of coronary lesions in patients with acute coronary syndrome
|
|
TANG Dongjuan, JIANG Lai, JIANG Ye
|
|
表1 各组一般临床资料比较
|
Tab 1 Comparison of clinical baseline data among the groups
|
|
| Item | Mild group (n=30) | Moderate group (n=21) | Severe group (n=23) | P value |
|---|
| Age/year | 64.6±12.2 | 63.1±12.2 | 63.9±8.5 | 0.903 | | Gender/(male/female)/n | 21/9 | 19/2 | 19/4 | 0.191 | | Diabetes/n(%) | 6 (20.0) | 8 (38.1) | 8 (34.8) | 0.319 | | CHD/n(%) | 6 (20.0) | 5 (23.8) | 3 (13.0) | 0.658 | | Smoking/n(%) | 16 (53.3) | 11 (52.4) | 12 (52.2) | 0.996 | | Hypertension/n(%) | 19 (63.3) | 13 (61.9) | 13 (56.5) | 0.879 | | HDL-C/(mmol·L-1) | 1.22±0.26 | 1.19±0.27 | 1.22±0.21 | 0.867 | | LDL-C/(mmol·L-1) | 2.70±0.88 | 2.56±0.66 | 2.91±0.97 | 0.414 | | Mb/(ng·mL-1) | 43.00 (19.38‒234.45) | 52.80 (24.65‒123.85) | 113.20 (51.20‒259.50) | 0.392 | | CK-MB/(ng·mL-1) | 2.95 (1.45‒42.25) | 3.30 (2.10‒7.30) | 4.40 (2.50‒21.30) | 0.528 | | cTnI/(ng·mL-1) | 0.15 (0.02‒1.57) | 0.12 (0.03‒0.20) | 0.15 (0.05‒0.74) | 0.660 | | LVEF/% | 56.26±7.03 | 57.97±7.51 | 58.43±6.22 | 0.795 | | miR-499 | 3.36±1.99 | 4.81±1.66 | 6.79±2.34 | 0.000 |
|
|
|